“MIDC introduced us to the American market, which developed OHK’s first sales in the USA. Those first sales led to our account base in Baltimore, which constitutes more than 50% of the hospitals we service and our company’s backbone. The sales activity has allowed employment of several sales reps in Maryland and development of the company across the northeast.”
Oren Gavriely
Chief Executive Officer
OHK Medical Devices“Since my first visit to Israel in 2006, I have felt an incredibly strong personal connection [to the country]. Through my participation in the MIDC, it is my hope to contribute to the continued prosperity of Israel and its people, while helping Maryland grow stronger economically.”
Jeffrey R. Elkin
Chief Operating Officer
Advance Business Systems“It is a testament to our world-class bioscience industry here in Maryland that we can attract Israeli global powerhouses and companies that are committed to investing in Maryland. Maryland and Israel share many strengths in the technology and bioscience industries and we look forward to doing business with Israeli companies considering expanding or locating offices in Maryland. … I have had the opportunity to lead a successful trade mission to Israel and have witnessed first hand, through our partner the Maryland/Israel Development Center, the successful partnership. I am optimistic about continued opportunities.”
Martin O’Malley, Governor
The State of Maryland“It’s an honor to work with the Maryland/Israel Development Center to attract companies from Israel in order to create jobs and continue to build on our mutually unparalleled assets – our world-class workforces, our top-rated education systems and our superior business climates. Maryland and Israel will continue to be competitive and strong partners in the global economy.”
Christian S. Johansson, Secretary
Department of Business and Economic Development
The State of Maryland“At an event sponsored by the Maryland/Israel Development Center, as part of its MarketReach America program, 20/20 GeneSystems was introduced to the Israeli biotech company ImmunArray. Subsequently we formed a strong collaboration with them and were jointly awarded a $1 million BIRD grant to share on the development of an early detection blood test for lung cancer.”
Jonathan Cohen, President and CEO
20/20 GeneSystems, Inc.“I became active in Maryland/Israel Development Center because of my love of technology, Israel and business. It is so gratifying to work with a company that is trying to find its niche in the U.S. market. We help them with networking and refining their product and market strategies so the Israeli company will be successful in Maryland and the U.S. I have the pleasure of working with a company that I was introduced to in a MarketReach program almost them years ago. Not only am I still working with them, I have new friends!
Beth S. Perlman, Community Volunteer